Kathleen Laporte Overview
- Investor Type
-
Angel
- Investments
-
1
- Portfolio
-
1
Kathleen Laporte General Information
Description
Ms. Kathleen LaPorte serves as President and Chief Executive Officer at Nodality. She is a Board Director and Compensation Committee Chair at 89bio. She serves as a Board Member at Bolt Biotherapeutics. She serves as Advisor at HealthyOps. She has a 25-year successful track record of guiding the growth of leading biopharmaceutical, diagnostic and digital health companies with breakthrough technologies. She was a Founding Partner of New Leaf Venture Partners from its inception as a spin-out of the Sprout Group, where she served as General Partner. In addition, Ms. LaPorte was co-founder of angel investing group Health Tech Capital in the digital health arena. Prior to this, she was a Principal at venture capital firm Asset Management Company. Ms. LaPorte received her B.S. degree in biology from Yale University and her MBA degree from Stanford University Graduate School of Business. She serves as a Board Member at Elysium Therapeutics.
Business Details
Primary Investor Type
Corporate Office
- 170 Harbor Way
- Suite 200
- South San Francisco, CA 94080
- United States
Kathleen Laporte Investments (1)
Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
---|---|---|---|---|---|---|
HealthyOps | Enterprise Systems (Healthcare) | Generating Revenue |
Kathleen Laporte Investments by Industry, Year, and Region
Kathleen Laporte Team (1)
Name | Title | Deals | Funds | Boards | Office |
---|---|---|---|---|---|
Kathleen Laporte | Angel Investor | South San Francisco, CA |
Kathleen Laporte FAQs
-
Who is Kathleen Laporte?
Kathleen Laporte is an angel Investor who has made 1 investment.
-
What kind of investor is Kathleen Laporte?
Kathleen Laporte is an angel investor.
-
What does Kathleen Laporte do?
As an angel investor, Kathleen Laporte invests personal money into promising companies, typically in exchange for equity.
-
How many board seats does Kathleen Laporte hold?
Kathleen Laporte holds 6 board seats including CERo Therapeutics, Q32 Bio, 89bio, Bolt Biotherapeutics, and Precipio.
-
What has Kathleen Laporte invested in?
Kathleen Laporte has invested in HealthyOps within the Enterprise Systems (Healthcare) industry.
-
What has Kathleen Laporte invested in recently?
Kathleen Laporte's latest investment was on HealthyOps, a company within the Enterprise Systems (Healthcare) industry.
in
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »